NEW YORK (GenomeWeb) — Kapa Biosystems said today that it has signed a three-year exclusive distribution agreement with Nippon Genetics.
The agreement extends an existing seven-year relationship between the companies and enables Nippon to continue marketing, distributing, and servicing Kapa's genomics reagents in Japan.
Kapa, based in Wilmington, Mass., sells reagents for use in PCR, qPCR, next-generation sequencing, and molecular diagnostics. Nippon is headquartered in Tokyo and provides a range of genomic and molecular biology research products for applications such as nucleic acid separation and purification, electrophoresis, PCR, real-time PCR, and NGS library prep.
"We are seeing broad adoption and strong demand for our innovative products not only in Japan, but across the Asia Pacific, European, and North American regions," Jean-Christophe Hatinguais, director of international sales at Kapa Biosystems, said in a statement. "We are now focused on extending our global reach by increasing our strategic investments and expanding our distribution network in key markets."